These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9553741)

  • 1. Alpha 1-antichymotrypsin mutations in patients with chronic obstructive pulmonary disease.
    Sandford AJ; Chagani T; Weir TD; Paré PD
    Dis Markers; 1998 Feb; 13(4):257-60. PubMed ID: 9553741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between alpha-1-antichymotrypsin polymorphism and susceptibility to chronic obstructive pulmonary disease.
    Ishii T; Matsuse T; Teramoto S; Matsui H; Hosoi T; Fukuchi Y; Ouchi Y
    Eur J Clin Invest; 2000 Jun; 30(6):543-8. PubMed ID: 10849024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A leucine-to-proline substitution causes a defective alpha 1-antichymotrypsin allele associated with familial obstructive lung disease.
    Poller W; Faber JP; Weidinger S; Tief K; Scholz S; Fischer M; Olek K; Kirchgesser M; Heidtmann HH
    Genomics; 1993 Sep; 17(3):740-3. PubMed ID: 8244391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha 1-antitrypsin TAQ I polymorphism and alpha 1-antichymotrypsin mutations in patients with obstructive pulmonary disease.
    Benetazzo MG; Gilè LS; Bombieri C; Malerba G; Massobrio M; Pignatti PF; Luisetti M
    Respir Med; 1999 Sep; 93(9):648-54. PubMed ID: 10542979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mis-sense mutation of alpha 1-antichymotrypsin gene and chronic lung disease.
    Samilchuk EI; Chuchalin AG
    Lancet; 1993 Sep; 342(8871):624. PubMed ID: 8102759
    [No Abstract]   [Full Text] [Related]  

  • 6. Mis-sense mutation of alpha 1-antichymotrypsin gene associated with chronic lung disease.
    Poller W; Faber JP; Scholz S; Weidinger S; Bartholomé K; Olek K; Eriksson S
    Lancet; 1992 Jun; 339(8808):1538. PubMed ID: 1351206
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of alpha(1)-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis.
    Mahadeva R; Sharples L; Ross-Russell RI; Webb AK; Bilton D; Lomas DA
    Thorax; 2001 Jan; 56(1):53-8. PubMed ID: 11120905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic risk factors for chronic obstructive pulmonary disease (COPD)].
    Miki M; Satoh K
    Nihon Rinsho; 1999 Sep; 57(9):1954-8. PubMed ID: 10497389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular basis of alpha 1-antichymotrypsin deficiency in a heterozygote with liver and lung disease.
    Faber JP; Poller W; Olek K; Baumann U; Carlson J; Lindmark B; Eriksson S
    J Hepatol; 1993 Jul; 18(3):313-21. PubMed ID: 8228125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complex search for antiprotease-protease enzyme gene polymorphisms in patients with chronic obstructive pulmonary diseases].
    Ianbaeva DG; Korytina GF; Viktorova TV
    Mol Biol (Mosk); 2004; 38(6):973-9. PubMed ID: 15612581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The search for susceptibility genes of COPD.
    Luisetti M; Pignatti PF
    Monaldi Arch Chest Dis; 1995 Jan; 50(1):28-32. PubMed ID: 7538005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease.
    Gooptu B; Hazes B; Chang WS; Dafforn TR; Carrell RW; Read RJ; Lomas DA
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):67-72. PubMed ID: 10618372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology: a key to better understanding of chronic obstructive lung disease.
    Snider GL
    Monaldi Arch Chest Dis; 1995 Jan; 50(1):3-6. PubMed ID: 7538006
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved phenotyping of alpha 1-antichymotrypsin (ACT) by isoelectric focusing and immunoprinting: first demonstration of a deficient protein variant in the ACT system.
    Weidinger S; Poller W; Faber JP; Schwarzfischer F
    Electrophoresis; 1992; 13(9-10):778-80. PubMed ID: 1459110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation in the 3' region of the alpha-1-antitrypsin gene and chronic obstructive pulmonary disease.
    Sandford AJ; Spinelli JJ; Weir TD; Paré PD
    J Med Genet; 1997 Oct; 34(10):874-5. PubMed ID: 9350828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease inhibitors in chronic obstructive pulmonary disease.
    Barnett TB; Gottovi D; Johnson AM
    Am Rev Respir Dis; 1975 May; 111(5):587-93. PubMed ID: 1079422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between alpha 1-antichymotrypsin polymorphism, Alzheimer's disease, and allele epsilon 4 of apolipoprotein E.
    Müller U; Bödeker RH; Gerundt I; Kurz A
    Neurology; 1996 Dec; 47(6):1575-7. PubMed ID: 8960749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy.
    Cox DW; Hoeppner VH; Levison H
    Am Rev Respir Dis; 1976 May; 113(5):601-6. PubMed ID: 1083700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic risk factors for chronic obstructive pulmonary disease.
    Sandford AJ; Weir TD; Paré PD
    Eur Respir J; 1997 Jun; 10(6):1380-91. PubMed ID: 9192947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis.
    Silverman EK; Chapman HA; Drazen JM; Weiss ST; Rosner B; Campbell EJ; O'DONNELL WJ; Reilly JJ; Ginns L; Mentzer S; Wain J; Speizer FE
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1770-8. PubMed ID: 9620904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.